# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001213900-25-036089
Filing Date
2025-04-28
Accepted
2025-04-28 16:20:08
Documents
4

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFINITIVE ADDITIONAL MATERIALS | ea0239765-defa14a_synergy.htm | DEFA14A | 11636
2 | GRAPHIC | image_001.jpg | GRAPHIC | 420780
3 | GRAPHIC | image_002.jpg | GRAPHIC | 363824
4 | GRAPHIC | image_003.jpg | GRAPHIC | 291082
| Complete submission text file | 0001213900-25-036089.txt |  | 1439087

Mailing Address 865 SPRING STREET WESTBROOK ME 04092
Business Address 865 SPRING STREET WESTBROOK ME 04092 615-939-9004
Synergy CHC Corp. (Filer) CIK: 0001562733 (see all company filings)

EIN.: 990379440 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-42374 | Film No.: 25880667
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)